comparemela.com
Home
Live Updates
Xuehai Liang - Breaking News
Pages:
Xuehai Liang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Biotech startup Arnatar raises $50m Series A round to build China presence
Founded in 2022, Arnatar specialises in antisense drug discovery and development.
United states
San diego
Xuehai liang
Yanfeng wang
Transfar group
Merck co
Valliance capital
Ionis pharmaceuticals
Legend holdings
Arnatar therapeutics
Eight roads
Huajin capital
Gaorong capital
Jifeng ventures
New alliance capital
Yijing capital
vimarsana © 2020. All Rights Reserved.